Pancreas-Preserving Approach to “Paraduodenal Pancreatitis” Treatment: Why, When, and How? Experience of Treatment of 62 Patients with Duodenal Dystrophy

<table>Microphotograph. Patient 47 y.o. Heterotopia of the pancreas tissue (acinuses—A and ducts—D) in the duodenal wall. Hematoxylin-eosin, ×100.</table>

BioMed Research International

fig9

Figure 9

Figure 9: Pancreas-Preserving Approach to “Paraduodenal Pancreatitis” Treatment: Why, When, and How? Experience of Treatment of 62 Patients with Duodenal Dystrophy 

Figure 9 | Pancreas-Preserving Approach to “Paraduodenal Pancreatitis” Treatment: Why, When, and How? Experience of Treatment of 62 Patients with Duodenal Dystrophy 